Glipizide
Glipizide[edit]
Introduction[edit]
Glipizide is an oral hypoglycemic medication used primarily in the management of Type 2 Diabetes. It is available as a tablet and is known under the brand name Glucotrol, manufactured by Pfizer Inc.
Overview[edit]
Glipizide is classified as a sulfonylurea, a group of medications that work by stimulating insulin secretion from the pancreatic beta cells. It is commonly prescribed in the treatment of Type 2 Diabetes when diet and exercise alone are not sufficient to control blood sugar levels.
Dosage and Administration[edit]
The medication is available in a 2.5mg dosage, among others. The starting dose is typically low to minimize the risk of hypoglycemia and then gradually increased based on the patient's response.
Mechanism of Action[edit]
Glipizide works by increasing insulin production in the pancreas, which helps lower blood glucose levels. It is part of a broader treatment plan that includes diet, exercise, and possibly other medications.
Side Effects and Precautions[edit]
Common side effects of Glipizide include hypoglycemia, weight gain, and gastrointestinal issues. Patients should be aware of the signs of low blood sugar and how to manage them.
Interactions[edit]
Glipizide may interact with other medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), other antidiabetic drugs, alcohol, and certain antibiotics. Patients should inform their healthcare provider of all medications they are taking.
See Also[edit]
References[edit]
1. Pfizer Inc - Glipizide Information 2. National Center for Biotechnology Information - Glipizide in Type 2 Diabetes Management
External Links[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
